Why Canopy Growth Stock Climbed as Much as 20% on Monday

A glimmer of hope from the U.S. Congress may lead to renewed interest in marijuana investing.

| More on:
Cannabis stocks have fallen.
You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Canopy Growth (TSX:WEED) stock rose as much as 20% on Monday after more news regarding legalization from the United States Congress. However, the gains shrunk back slightly after the company made an announcement about an exchange transaction on Tuesday morning.

What happened

Canopy Growth stock climbed Monday on news that Congress could consider cannabis legalization very soon. While federal legalization remains unlikely in the near future, some good news could rally the entire sector.

What once seemed to be a dying industry even had short sellers losing interest. The industry has US$632 million in short interest, down from US$3.2 billion in May 2021. But with Congress meeting soon, there is a glimmer of hope that may lead to renewed interest in the industry.

So what?

Does this mean Canopy Growth stock will climb yet again? Not exactly. Shares of the company reached all-time highs of about $70 back in 2018, and those prices aren’t likely to come back any time soon. However, the stock may also have bottomed out, creating a scenario in which they could climb and fall over the next while.

At the very least, this means short interest is falling, resulting in a less volatile situation than before. And Canopy Growth stock and others could climb again as Senate Democrats plan to introduce a bill to decriminalize marijuana.

Now what

News has boosted stock prices for now, but this might not last long. The bill isn’t likely to pass. It needs 60 votes and faces tough odds once it reaches Senate Republicans. But it still gets the industry chatting again, and there is talk of other legislation that could be approved in the next few months.

Furthermore, experts predict legalization will eventually happen. When it does, Canopy Growth could become the largest marijuana producer in the world. For now, however, shares have fallen back slightly as the company announced the closure of an exchange transaction on Tuesday.

The cannabis company said it acquired and cancelled $263 million in outstanding notes. This was meant to deleverage its balance sheet and “preserve cash, and reduce interest payments” according to the company’s chief financial officer. However, the company didn’t exactly get a great price for the cancellation payment.

Foolish takeaway

So what does all of this mean for Motley Fool investors? There are some investors selling shares and taking profit while shares are up, but I wouldn’t recommend this. In fact, I wouldn’t recommend this when considering the market as a whole.

Shares are at their lowest not just for Canopy Growth stock, but the market in general. It’s simply not a good time to sell. The market trends upwards for those who are willing to wait. And frankly, everyone should be willing to wait at least a year before making any decisions about the current market.

With Canopy Growth stock, hopefully you got in as a long-term investment. Sure, growth is nice, but it’s been proven time and again that you get the most from companies you’re willing to hold for decades. 20 years from now, Canopy Growth stock will be up and legalization will have happened. And if you’ve sold, you’ll be looking back at your younger self and shaking your head.

As of this writing, shares of Canopy Growth stock are down 70% year-to-date, and up about 11% in the past week.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Amy Legate-Wolfe has positions in Canopy Growth. The Motley Fool has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »